Hutch News

Hutch News

Stories tagged 'immunotherapy research'

For cancer patients with HIV, immunotherapy appears safe

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials

Nov. 7, 2017 | By Mary Engel / Fred Hutch News Service

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials.

View story >


Science without borders

At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases

Oct. 16, 2017 | By Mary Engel / Fred Hutch Research Center

Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 29, 2017

Dr. Jennifer Adair, a clinical researcher at Fred Hutch, spoke recently at TEDxNashville about her vision of making gene therapy more accessible and affordable for treating diseases ranging from glioblastoma to HIV.

View story >


Dr. Hootie Warren takes helm of Fred Hutch Global Oncology

Immunotherapy researcher, cancer doctor set to lead a new worldwide revolution in care

July 6, 2017 | By Mary Engel / Fred Hutch News Service

Fred Hutch's new head of Global Oncology, Dr. Edus H. Warren, believes that the "breathtaking discoveries and advances" in immunotherapy and other areas that scientists are making here can be adapted to improve cancer care around the world.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 22, 2017

A new algorithm created by Dr. Philip Bradley and colleagues could aid the development of tools to decode T-cell receptor sequences and, ultimately, improve the diagnosis and treatment of cancers, reported this week in Nature.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

May 25, 2017

A team of Fred Hutch researchers led by principal investigator Dr. Eric Holland has received $400,000 for a two-year pilot study to test several novel immunotherapy approaches for glioma, an aggressive brain cancer. The study was made possible by the generous support of the Bezos family, which since 2009 has donated and leveraged more than $40 million to Fred Hutch for immunotherapy research.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.